TCRX TScan Therapeutics, Inc.

NASDAQ
$0.32

TScan Therapeutics, Inc. (TCRX) SEC Filings

Everything TCRX has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

38 filings
Date Form Filing
8-K
SCHEDULE 13G
8-K Executive Change · Other
8-K Delisting · Executive Change · Investor Presentation · Other · Other Event · Other Reg Fd · Reg Fd · Restructuring
8-K Agreement Terminated · Material Agreement
10-Q
4
4
4
4
4
4
10-Q
10-K
4
4
4
4
4
4
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K/A
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.